SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
---|---|---|---|---|---|---|---|---|
23-May-13 2:36 PM View: | Savient Pharmaceuticals Inc. (SVNTQ) | 22-May-13 | Market Sale (Planned) | 1,020 | $0.57 | $581.40 | (< 1%) 308.46K to 307.44K | 2% |
25-Feb-13 4:35 PM View: | Savient Pharmaceuticals Inc. (SVNTQ) | 25-Feb-13 | Market Sale (Planned) | 375 | $0.99 | $371.25 | (< 1%) 296.37K to 296.0K | 43% |
06-Feb-13 10:17 AM View: | Savient Pharmaceuticals Inc. (SVNTQ) | 04-Feb-13 | Market Sale (Planned) | 62,200 | $1.01 | $62,854.00 | (17%) 358.57K to 296.37K | 45% |
27-Nov-12 4:12 PM View: | Savient Pharmaceuticals Inc. (SVNTQ) | 26-Nov-12 | Market Sale (Planned) | 950 | $1.16 | $1,102.00 | (< 1%) 359.52K to 358.57K | 52% |
27-Nov-12 4:12 PM View: | Savient Pharmaceuticals Inc. (SVNTQ) | 31-Aug-12 | Grant | 2,434 | $1.12 | $2,730.95 | < 1% 357.09K to 359.52K | |
24-Aug-12 8:05 PM View: | Savient Pharmaceuticals Inc. (SVNTQ) | 22-Aug-12 | Market Sale (Planned) | 984 | $1.00 | $985.97 | (< 1%) 349.56K to 348.58K | 44% |
27-Nov-12 4:12 PM View: | Savient Pharmaceuticals Inc. (SVNTQ) | 31-May-12 | Grant | 5,888 | $0.62 | $3,624.65 | 2% 351.2K to 357.09K | |
22-May-12 4:24 PM View: | Savient Pharmaceuticals Inc. (SVNTQ) | 22-May-12 | Market Sale (Planned) | 942 | $0.82 | $772.44 | (< 1%) 350.5K to 349.56K | 30% |
27-Nov-12 4:12 PM View: | Savient Pharmaceuticals Inc. (SVNTQ) | 29-Feb-12 | Grant | 2,622 | $1.71 | $4,479.69 | < 1% 348.58K to 351.2K | |
23-Feb-12 12:22 PM View: | Savient Pharmaceuticals Inc. (SVNTQ) | 22-Feb-12 | Market Sale (Planned) | 4,100 | $2.06 | $8,446.00 | (1%) 354.6K to 350.5K | 72% |
13-Feb-12 6:33 AM View: | Savient Pharmaceuticals Inc. (SVNTQ) | 01-Feb-12 | Grant | 310,000 | $2.26 | $700,600.00 | 695% 44.6K to 354.6K | (75%) |
13-Feb-12 6:33 AM View: | Savient Pharmaceuticals Inc. (SVNTQ) | 30-Nov-11 | Grant | 381 | $2.13 | $811.53 | < 1% 44.22K to 44.6K | |
22-Nov-11 6:41 PM View: | Savient Pharmaceuticals Inc. (SVNTQ) | 21-Nov-11 | Market Purchase | 4,000 | $2.29 | $9,160.00 | 10% 40.0K to 44.0K | (75%) |
13-Feb-12 6:33 AM View: | Savient Pharmaceuticals Inc. (SVNTQ) | 31-Aug-11 | Grant | 222 | $3.66 | $812.52 | < 1% 44.0K to 44.22K | |
23-Feb-11 4:24 PM View: | Savient Pharmaceuticals Inc. (SVNTQ) | 21-Feb-11 | Grant | 40,000 | $9.98 | $399,200.00 | 100% 0 to 40.0K | (94%) |